Open AccessClassification of Patients With GH Disorders May Vary According to the IGF-I Assay
Author(s) -
Maria Mavromati,
Emmanuelle Kuhn,
Hélène Agostini,
Sylvie BraillyTabard,
Catherine Massart,
MarieLiesse Piketty,
Armelle Arnoux,
Jacques Young,
Jean–Claude Souberbielle,
Philippe Chanson
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-00202
Subject(s) - concordance , acromegaly , medicine , population , growth hormone , endocrinology , hormone , environmental health
Insulinlike growth factor I (IGF-I) measurement is essential for the diagnosis and management of growth hormone (GH) disorders. However, patient classification may vary substantially according to the assay technique.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom